Use of the Wearable Cardioverter‐Defibrillator Among Patients With Myocarditis and Reduced Ejection Fraction or Ventricular Tachyarrhythmia: Data From a Multicenter Registry

Ibrahim El‐Battrawy(University Hospitals of the Ruhr-University of Bochum), Thomas Beiert(University Hospital Bonn), Nazha Hamdani(University Hospitals of the Ruhr-University of Bochum), David Tenbrink(BG University Hospital Bergmannsheil Bochum), Mohammad Abumayyaleh(Heidelberg University), Boldizsar Kovacs(University of Michigan), Katharina Koepsel(BG University Hospital Bergmannsheil Bochum), Tobias C. Dreher(Heidelberg University), Ardan M. Saguner(University of Zurich), Jacqueline Kowitz(Heidelberg University), Assem Aweimer(BG University Hospital Bergmannsheil Bochum), İbrahim Akın(University of Mannheim), Hendrik Lapp(University Hospital Bonn), Andreas Mügge(Roche (Switzerland)), Stephanie Rosenkaimer(Heidelberg University), Fırat Duru(University of Malta), Julia W. Erath(Goethe University Frankfurt), Thomas Kuntz(Klinikum St. Georg), Dong‐In Shin(Witten/Herdecke University), Christian Blockhaus(Witten/Herdecke University), Norbert Klein(Klinikum St. Georg), Michael Gotzmann(St. Josef-Hospital)
Journal of the American Heart Association
September 8, 2023
Cited by 17


Related Papers